ATE402258T1 - Gene differentiell experimiert in brudtkrebs - Google Patents

Gene differentiell experimiert in brudtkrebs

Info

Publication number
ATE402258T1
ATE402258T1 AT01942365T AT01942365T ATE402258T1 AT E402258 T1 ATE402258 T1 AT E402258T1 AT 01942365 T AT01942365 T AT 01942365T AT 01942365 T AT01942365 T AT 01942365T AT E402258 T1 ATE402258 T1 AT E402258T1
Authority
AT
Austria
Prior art keywords
experimented
major cancer
gene differential
seq
cancer cells
Prior art date
Application number
AT01942365T
Other languages
English (en)
Inventor
Joerg Kaufmann
Greg Harrowe
Christoph Reinhard
Sanmao Kang
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE402258T1 publication Critical patent/ATE402258T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01942365T 2000-01-10 2001-01-09 Gene differentiell experimiert in brudtkrebs ATE402258T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17546200P 2000-01-10 2000-01-10

Publications (1)

Publication Number Publication Date
ATE402258T1 true ATE402258T1 (de) 2008-08-15

Family

ID=22640304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942365T ATE402258T1 (de) 2000-01-10 2001-01-09 Gene differentiell experimiert in brudtkrebs

Country Status (10)

Country Link
US (1) US7605246B2 (de)
EP (2) EP1985701B1 (de)
JP (2) JP5250168B2 (de)
AT (1) ATE402258T1 (de)
AU (1) AU2001229367A1 (de)
DE (1) DE60134956D1 (de)
ES (2) ES2311016T3 (de)
HK (1) HK1118861A1 (de)
PT (1) PT1248841E (de)
WO (1) WO2001051515A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081517B2 (en) * 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
DE102011110592A1 (de) 2011-08-18 2013-02-21 Rena Gmbh Verfahren zum Konditionieren von flachen Gegenständen
CN112837822B (zh) * 2020-09-24 2023-05-02 广州市疾病预防控制中心(广州市卫生检验中心、广州市食品安全风险监测与评估中心、广州医科大学公共卫生研究院) 预测covid-19患者发生轻至重度进展的标志物及试剂盒和建立方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
EP0127839B1 (de) 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Verfahren zur Herstellung eines rekombinanten Baculovirus-Expressionsvektors
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
IL77186A0 (en) 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
WO1990003430A1 (en) 1988-09-23 1990-04-05 Cetus Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
DK0616802T3 (da) 1992-08-13 1998-10-19 Teikoku Seiyaku Kk Oralt præparat til frigivelse i de nedre fordøjelseskanaler
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
CA2388922A1 (en) * 1999-11-19 2001-05-25 Human Genome Sciences, Inc. 23 human secreted proteins

Also Published As

Publication number Publication date
PT1248841E (pt) 2008-09-15
AU2001229367A1 (en) 2001-07-24
EP1985701A2 (de) 2008-10-29
DE60134956D1 (de) 2008-09-04
JP5250168B2 (ja) 2013-07-31
HK1118861A1 (en) 2009-02-20
EP1248841B1 (de) 2008-07-23
US7605246B2 (en) 2009-10-20
WO2001051515A2 (en) 2001-07-19
WO2001051515A3 (en) 2002-01-24
EP1248841A2 (de) 2002-10-16
JP2003519480A (ja) 2003-06-24
US20020004239A1 (en) 2002-01-10
EP1985701A3 (de) 2009-01-07
ES2311016T3 (es) 2009-02-01
EP1985701B1 (de) 2012-05-30
ES2386317T3 (es) 2012-08-17
JP2012143242A (ja) 2012-08-02

Similar Documents

Publication Publication Date Title
ATE386804T1 (de) Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
AU1726199A (en) Metastatic cancer regulated gene
ATE190313T1 (de) Dns-sequenz und kodiertes brustdrüsenspezifisisches brustkrebsprotein
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
TR200003685T1 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin
HK1148783A1 (zh) 用於***腺的預後的基因表達標記
ATE422536T1 (de) Zusammensetzungen und methoden zur diagnose von tumoren
WO1999014327A3 (en) Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
ES2329689T3 (es) Composiciones y procedimientos para el diagnostico de tumores.
HK1118861A1 (en) Genes differentially expressed in breast cancer
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
DE60113968D1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
WO2003079884A3 (en) Methods for diagnosis and prognosis of cancer
DE69837935D1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
EP1693457A3 (de) In metastasierenden Brust- und Darmkrebs regulierte Gene
WO2002042776A3 (en) Compositions and methods relating to prostate specific genes and proteins
WO1999043812A3 (en) Dlc-1 gene, a putative tumors suppressor gene
WO2002042460A3 (en) Compositions and methods relating to colon specific genes and proteins
WO2002038810A3 (en) Compositions and methods relating to prostate specific genes and proteins
ATE391176T1 (de) Neues gen mit induzierter expression in menschlichen metastatischen tumorzellen
WO2002040535A3 (en) Compositions and methods relating to ovary specific genes and proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties